Adiponectin
Adiponectin (Acrp30, AdipoQ)
244 Amino Acids · MW: ~26.4 kDa (monomer)
Amino Acids
244
Molecular Weight
~26.4 kDa (monomer)
Half-life
~2-4 h
Research Score
5.0
Studies
86
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Adiponectin?
Adiponectin is a 244-amino-acid adipokine that improves insulin sensitivity and fatty-acid oxidation. It is one of the best-known upstream activators of AMPK in liver and skeletal muscle.
Key Benefits & Mechanisms
insulin sensitivity
fatty-acid oxidation
AMPK activation
Research Summary
Preclinical and translational studies link adiponectin signaling with better glycemic control, lower inflammation, and improved lipid handling. Recombinant adiponectin and receptor-targeting approaches remain research tools rather than approved diabetes therapies.
Related Peptides
Insulin Lispro
Insulin lispro (B28-Lys, B29-Pro human insulin analog)
A rapid-acting insulin analog with a reversed B28/B29 sequence that speeds absorption after subcutaneous injection. It is used to reduce postprandial hyperglycemia and to support flexible mealtime insulin strategies.
Diabetes & MetabolicInsulin Aspart
Insulin aspart (B28-Asp human insulin analog)
A rapid-acting insulin analog with an amino-acid substitution at B28 that promotes faster absorption after injection. It is widely used to blunt postprandial glucose excursions in diabetes research and clinical practice.
Diabetes & MetabolicInsulin Glargine
Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)
A long-acting basal insulin analog engineered for slow release from the subcutaneous depot. It provides relatively flat day-long insulin coverage and is used to control fasting glucose.
Diabetes & MetabolicInsulin Degludec
Insulin degludec (desB30, acylated ultra-long-acting insulin analog)
An ultra-long-acting insulin analog designed with a fatty-acid side chain to form a slow-release depot. It is valued for very flat pharmacokinetics and flexible once-daily basal dosing.
Diabetes & Metabolic